##  [Novartis Phase III study shows RLX030 improved symptoms and reduced deaths by one-third in patients with acute heart failure](/us-en/news/media-releases/novartis-phase-iii-study-shows-rlx030-improved-symptoms-and-reduced-deaths-one-third-patients-acute-heart-failure-0 "Novartis Phase III study shows RLX030 improved symptoms and reduced deaths by one-third in patients with acute heart failure") 

  Nov 07, 2012